Rewas Bio Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Rewas Bio Science
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nirmal Dwivedi and Yerabahalli Srinivasa serve as directors at the Company.
- CIN/LLPIN
U24290KA2022PTC164039
- Company No.
164039
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rewas Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yerabahalli Srinivasa  | Director | 31-Oct-2023 | Current |
| Nirmal Dwivedi | Director | 20-Jul-2022 | Current |
Financial Performance of Rewas Bio Science.
Enhance accessibility to Rewas Bio Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rewas Bio Science?
Unlock access to Rewas Bio Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pan Oceanic Seed Solutions Private LimitedActive 17 years 4 monthsNirmal Dwivedi is a mutual person
Tene Agricultural Solutions Private LimitedActive 12 years 10 monthsYerabahalli Srinivasa is a mutual person
- Global Seed Logistics Private LimitedActive 1 year 9 months
Yerabahalli Srinivasa is a mutual person
- Neytiri Eywafarm Agritech Private LimitedActive 2 months 13 days
Yerabahalli Srinivasa is a mutual person
- Rightcrop Agricultural Services Private LimitedActive 4 years 6 months
Yerabahalli Srinivasa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rewas Bio Science?
Rewas Bio Science has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rewas Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rewas Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
